Six-month reprieve from price hike on popular diabetes drug 0 17.03.2023 08:18 Sydney Morning Herald Drug manufacturer Novo Nordisk had planned to remove Fiasp from the PBS from April 1, which would lift the yearly cost of the fast-acting insulin product by more than $2000. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
